889 related articles for article (PubMed ID: 12535572)
41. [Expression and regulation of drug transporters in placenta].
Bai MR; Sun DL; Jiang HD; Zheng CH
Yao Xue Xue Bao; 2016 Jun; 51(6):879-85. PubMed ID: 29878741
[TBL] [Abstract][Full Text] [Related]
42. Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of (99m)Tc-tetrofosmin.
Chen WS; Luker KE; Dahlheimer JL; Pica CM; Luker GD; Piwnica-Worms D
Biochem Pharmacol; 2000 Aug; 60(3):413-26. PubMed ID: 10856437
[TBL] [Abstract][Full Text] [Related]
43. ABC Transporters in Extrahepatic Tissues: Pharmacological Regulation in Heart and Intestine.
Villanueva S; Zhang W; Zecchinati F; Mottino A; Vore M
Curr Med Chem; 2019; 26(7):1155-1184. PubMed ID: 29589524
[TBL] [Abstract][Full Text] [Related]
44. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
[TBL] [Abstract][Full Text] [Related]
45. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
46. Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier.
Kabanov AV; Batrakova EV; Miller DW
Adv Drug Deliv Rev; 2003 Jan; 55(1):151-64. PubMed ID: 12535579
[TBL] [Abstract][Full Text] [Related]
47. Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier.
Eisenblätter T; Hüwel S; Galla HJ
Brain Res; 2003 May; 971(2):221-31. PubMed ID: 12706238
[TBL] [Abstract][Full Text] [Related]
48. Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites.
Patel M; Taskar KS; Zamek-Gliszczynski MJ
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S23-39. PubMed ID: 27385177
[TBL] [Abstract][Full Text] [Related]
49. Avoiding barriers to PET radioligand development: cellular assays of brain efflux transporters.
Hall MD; Pike VW
J Nucl Med; 2011 Mar; 52(3):338-40. PubMed ID: 21321273
[No Abstract] [Full Text] [Related]
50. Role of ATP-binding cassette (ABC) transporters in interactions between natural products and drugs.
Aszalos A
Curr Drug Metab; 2008 Dec; 9(10):1010-8. PubMed ID: 19075617
[TBL] [Abstract][Full Text] [Related]
51. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
52. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
Cotte S; von Ahsen N; Kruse N; Huber B; Winkelmann A; Zettl UK; Starck M; König N; Tellez N; Dörr J; Paul F; Zipp F; Lühder F; Koepsell H; Pannek H; Montalban X; Gold R; Chan A
Brain; 2009 Sep; 132(Pt 9):2517-30. PubMed ID: 19605531
[TBL] [Abstract][Full Text] [Related]
53. Detergent-free purification of ABC (ATP-binding-cassette) transporters.
Gulati S; Jamshad M; Knowles TJ; Morrison KA; Downing R; Cant N; Collins R; Koenderink JB; Ford RC; Overduin M; Kerr ID; Dafforn TR; Rothnie AJ
Biochem J; 2014 Jul; 461(2):269-78. PubMed ID: 24758594
[TBL] [Abstract][Full Text] [Related]
54. Effect of the ATP-binding cassette transporter ABCG2 on pharmacokinetics: experimental findings and clinical implications.
Schnepf R; Zolk O
Expert Opin Drug Metab Toxicol; 2013 Mar; 9(3):287-306. PubMed ID: 23289909
[TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetic assessment of multiple ATP-binding cassette transporters: the power of combination knockout mice.
Lagas JS; Vlaming ML; Schinkel AH
Mol Interv; 2009 Jun; 9(3):136-45. PubMed ID: 19592674
[TBL] [Abstract][Full Text] [Related]
56. ABC transporters and isothiocyanates: potential for pharmacokinetic diet-drug interactions.
Telang U; Ji Y; Morris ME
Biopharm Drug Dispos; 2009 Oct; 30(7):335-44. PubMed ID: 19623673
[TBL] [Abstract][Full Text] [Related]
57. Drug transporters in drug efficacy and toxicity.
DeGorter MK; Xia CQ; Yang JJ; Kim RB
Annu Rev Pharmacol Toxicol; 2012; 52():249-73. PubMed ID: 21942630
[TBL] [Abstract][Full Text] [Related]
58. ABC transporters in the protozoan parasite Leishmania.
Pérez-Victoria JM; Parodi-Talice A; Torres C; Gamarro F; Castanys S
Int Microbiol; 2001 Sep; 4(3):159-66. PubMed ID: 11820434
[TBL] [Abstract][Full Text] [Related]
59. Placental ABC Transporters: Biological Impact and Pharmaceutical Significance.
Joshi AA; Vaidya SS; St-Pierre MV; Mikheev AM; Desino KE; Nyandege AN; Audus KL; Unadkat JD; Gerk PM
Pharm Res; 2016 Dec; 33(12):2847-2878. PubMed ID: 27644937
[TBL] [Abstract][Full Text] [Related]
60. Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy.
Keppler D
Handb Exp Pharmacol; 2011; (201):299-323. PubMed ID: 21103974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
